ATE229339T1 - Inhibitor der immunoglobulin e antikörpererzeugung zur behandlung von typ i allergie-verwandten krankheiten - Google Patents

Inhibitor der immunoglobulin e antikörpererzeugung zur behandlung von typ i allergie-verwandten krankheiten

Info

Publication number
ATE229339T1
ATE229339T1 AT98900051T AT98900051T ATE229339T1 AT E229339 T1 ATE229339 T1 AT E229339T1 AT 98900051 T AT98900051 T AT 98900051T AT 98900051 T AT98900051 T AT 98900051T AT E229339 T1 ATE229339 T1 AT E229339T1
Authority
AT
Austria
Prior art keywords
allergy
treatment
type
related diseases
immunoglobulin
Prior art date
Application number
AT98900051T
Other languages
English (en)
Inventor
Hitoshi Oomori
Yoichi Ooiso
Ryosuke Sugihara
Original Assignee
Tayca Corp
Hitoshi Oomori
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tayca Corp, Hitoshi Oomori filed Critical Tayca Corp
Application granted granted Critical
Publication of ATE229339T1 publication Critical patent/ATE229339T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/831—Drug, bio-affecting and body treating compositions involving capsular polysaccharide of bacterium, e.g. polyribosyl ribitol phosphate

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT98900051T 1997-01-07 1998-01-05 Inhibitor der immunoglobulin e antikörpererzeugung zur behandlung von typ i allergie-verwandten krankheiten ATE229339T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP9013125A JPH10194979A (ja) 1997-01-07 1997-01-07 イムノグロブリンｅ抗体産生抑制剤
PCT/JP1998/000029 WO1998030224A1 (en) 1997-01-07 1998-01-05 Inhibitor of immunoglobulin e antibody production

Publications (1)

Publication Number Publication Date
ATE229339T1 true ATE229339T1 (de) 2002-12-15

Family

ID=11824450

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98900051T ATE229339T1 (de) 1997-01-07 1998-01-05 Inhibitor der immunoglobulin e antikörpererzeugung zur behandlung von typ i allergie-verwandten krankheiten

Country Status (6)

Country Link
US (1) US6423320B1 (de)
EP (1) EP0894001B1 (de)
JP (1) JPH10194979A (de)
AT (1) ATE229339T1 (de)
DE (1) DE69810024T2 (de)
WO (1) WO1998030224A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7063264B2 (en) 2001-12-24 2006-06-20 Digimarc Corporation Covert variable information on identification documents and methods of making same
AU2003221894A1 (en) 2002-04-09 2003-10-27 Digimarc Id Systems, Llc Image processing techniques for printing identification cards and documents
US20100111927A1 (en) * 2002-08-23 2010-05-06 Sunyoung Kim Compositions Comprising Actinidia and Methods of Use Thereof
KR100615389B1 (ko) 2002-08-23 2006-08-25 (주)헬릭서 다래 추출물을 함유하는 알러지성 질환 및 비알러지성염증 질환의 예방 및 개선용 건강 기능 식품
US20080175888A1 (en) * 2005-02-25 2008-07-24 Julie Lindemann Combination Therapy Comprising Actinidia and Steroids and Uses Thereof
JP5737646B2 (ja) * 2010-03-24 2015-06-17 森下仁丹株式会社 抗アレルギー剤
US10688169B2 (en) 2015-03-27 2020-06-23 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Vaccines against carbapenem-resistant Klebsiella pneumoniae

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4870053A (en) * 1980-09-19 1989-09-26 Roussel Uclaf Novel compositions and processes
EP0238739B1 (de) * 1986-03-27 1992-02-05 Swiss Serum and Vaccine Institute Berne Impfstoff des Klebsiella Kapsulpolysaccharids
US4755381A (en) * 1986-03-27 1988-07-05 Swiss Serum And Vaccine Institute Berne Klebsiella capsular polysaccharide vaccine
FR2620130B1 (fr) 1987-09-08 1990-01-12 Lipha Nouveaux polysaccharides hydrosolubles, leur procede d'obtention, leur application a titre de medicaments et preparation les renfermant
WO1990013600A1 (en) * 1989-05-04 1990-11-15 E.I. Du Pont De Nemours And Company Polymeric plasticizers for polyvinyl chloride
JPH0790003A (ja) * 1993-03-01 1995-04-04 Teika Corp 新規多糖類、その製造方法、新規多糖類の用途およびアゾトバクター・ベイジェリンキィーｔｎｍ１株
JP3453192B2 (ja) * 1994-06-01 2003-10-06 テイカ株式会社 新規多糖類、その製造方法、新規多糖類の用途およびアグロバクテリウム・ラディオバクターｔｎｍ２株
US5989874A (en) * 1995-03-27 1999-11-23 Tayca Corporation Humectant, antistatic agent, dispersant and film-forming agent having polysaccharide as active principle, preparation process of polysaccharides, and Kliebsiella ocytoca TNM-3 strain
EP0775490A4 (de) * 1995-06-05 1998-06-03 Tayca Corp Immunpotentiator

Also Published As

Publication number Publication date
JPH10194979A (ja) 1998-07-28
US6423320B1 (en) 2002-07-23
WO1998030224A1 (en) 1998-07-16
DE69810024T2 (de) 2003-09-25
US20020041885A1 (en) 2002-04-11
EP0894001A1 (de) 1999-02-03
DE69810024D1 (de) 2003-01-23
EP0894001B1 (de) 2002-12-11

Similar Documents

Publication Publication Date Title
NO2017027I1 (no) efmoroctocog alfa eller et biotilsvarende legemiddel ihht Artikkel 10(4) av Directive 2001/83/EC, som beskyttet av basispatentet.
ATE283264T1 (de) Zwischenprodukte zur herstellung von metallproteinasehemmern
MX9705005A (es) Inhibidores de la proteina de transferencia de trigliceridos microsomicos y metodo.
DE69632630D1 (de) Enzym mit aminopeptidaseactivität
ES2163644T3 (es) Procedimiento para la estabilizacion de proteinas en un medio acido con una pectina muy esterificada.
ES2062812T3 (es) Composicion detergente enzimatica y metodo para estabilizar enzimas.
CY1107628T1 (el) Ανθρωπινα ctla-4 αντισωματα και χρησεις αυτων
ATE324381T1 (de) Mutiertes scfv-fragment des okt-3 antikörpers
AR248044A1 (es) Una secuencia de adn que codifica anticuerpos monoclonales humanizados contra interleuquinas humanas, metodo de obtencion y de seleccion de dichos anticuerpos, vector recombinante y celula huesped.
MX9800760A (es) Metodos para el tratamiento del asma alergica.
NO952989L (no) Fremgangsmåte til refolding av proteiner
DE69832489D1 (de) Induktion von männlicher sterilität in pflanzen durch erhöhte expression von streptavidin
JP2001515920A5 (de)
ATE166883T1 (de) Monoklonale antikörper (mak) gegen tumorassoziierte antigene, ihre herstellung und verwendung
ATE502050T1 (de) Von dd 3b6/22 abgeleitete humanisierte antikörper mit spezifität für das d-dimer fragment von fibrin
ATE229339T1 (de) Inhibitor der immunoglobulin e antikörpererzeugung zur behandlung von typ i allergie-verwandten krankheiten
ATE114713T1 (de) Biomasse zur produktion von virus/virusantigen.
ATE206621T1 (de) Il-8 antagonisten zur behandlung von asthma
ATE285474T1 (de) Haemophilus adhäsionsproteinen
DE3689766D1 (de) Monoklonaler antikörper-inhibitor des plasminogenaktivators, hybridomen, herstellung monoklonaler antikörper und deren verwendung zur reinigung, beseitigung, inhibition oder zum testverfahren von inhibitoren.
DE69431603D1 (de) Oligopeptide hergeleitet von fragmenten des c-reaktiven proteins
FR2686898B1 (fr) Methode de production de la l-phenylalanine.
DE69917445D1 (de) Reinigung von carboxaldehyd
ATE309371T1 (de) Protein mit dnase-aktivität
DE69331094D1 (de) Verfahren zur Herstellung von essfertigen Getreideflocken

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties